J&J Developing Several Next-Generation COVID-19 Vaccines, Says CEO

(Reuters) – Johnson & Johnson is developing several next-generation COVID-19 vaccines against the emerging variants of the coronavirus, Chief Executive

Read more

States Prep for COVID-19 Vaccines for All Adults in May if Promised Supplies Arrive

(Reuters) – State public health departments are ready to begin giving COVID-19 shots to all adult residents if the White

Read more

Americans Seek Compensation for Failed COVID-19 Treatments From US Fund

(Reuters) – In March of last year, Steve Cicala took his wife, Susan, to the emergency room at Clara Maass

Read more

Canada Approves J&J’s COVID-19 Vaccine, Says Benefits Outweigh Risks

OTTAWA (Reuters) – Canada’s drug regulator has approved Johnson & Johnson’s COVID-19 vaccine, the fourth such shot to be given

Read more

Faster Vaccination Needed in Latin America to Curb Variants

BRASILIA (Reuters) – COVID-19 vaccines are helping reduce infections in North America but in Latin America vaccinations have hardly begun,

Read more

COVID Sickness Dropped 95.8% After Both Pfizer Shots: Israeli Health Ministry

JERUSALEM (Reuters) – The risk of illness from COVID-19 dropped 95.8% among people who received both shots of Pfizer’s vaccine,

Read more

South Africa Plans to Share AstraZeneca Vaccine, First J&J Shots Expected

JOHANNESBURG (Reuters) – South Africa plans to share 1 million AstraZeneca COVID-19 vaccine doses with other African countries, a senior

Read more

Raised Serum Amylase in COVID-19 Patients May Not Be Acute Pancreatitis

NEW YORK (Reuters Health) – A higher-than-normal serum amylase level in patients with COVID-19 does not necessarily indicate acute pancreatitis

Read more